Product Information: Palbociclib
Palbociclib
| Cat. No. | HXT-38566 |
|---|---|
| CAS. No. | 571190-30-2 |
| Category | API Standards |
| Stock Status | Instock |
| Molecular Formula | C24H29N7O2 |
| Molecular Weight | 447.53 mol/g |
| Application | Palbociclib (also known as compound number ) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
Get Quick Quote
Global Delivery
We deliver across the globe.
Quality
We follow strict QC for all synthesis.
Instant Support
We offer support 24x7.